Technology | January 19, 2010

New Suite of Tools Aids Cardiovascular Research

January 19, 2010 – A family of cardiovascular research products used to assess cardiac performance and hemodynamics, both in vivo and in vitro was launched today by iWorks. The systems, software and components are used for a number of research applications, including measuring and analyzing blood pressure, electrocardiograms, blood flow and cardiac output, pressure-volume, sonomicrometry dimension and volume, isolated Langendorff and working heart models and isolated tissue studies.

iWorx LabScribe2 recording and analysis software provides a comprehensive set of preconfigured routines to simplify data interpretation and analysis. Specific software modules for cardiovascular research are available to analyze pressure signals, blood flow data, ECG recordings, ventricular pressure-volume loops and sonomicrometry dimension data. The software can display up to 128 channels of data simultaneously at sampling rates as high as 100,000 samples/second.

iWorx cardiovascular research solutions include complete tissue baths systems, blood flow systems, and myograph systems. A wide range of transducers, amplifiers, signal conditioners, multi-channel data recorders and accessories can be used for in situ experiments, isolated heart preparations and isolated tissue protocols.

For more information: www.iworx.com.


Related Content

News | Cardiovascular Clinical Studies

May 2, 2024 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular ...

Home May 02, 2024
Home
News | Cardiovascular Clinical Studies

May 1, 2024 — A study in more than 3,000 US counties, with 315 million residents, has suggested that air pollution is ...

Home May 01, 2024
Home
News | Cardiovascular Clinical Studies

April 30, 2024 — Regenerative heart therapies involve transplanting cardiac muscle cells into damaged areas of the heart ...

Home April 30, 2024
Home
News | Cardiovascular Clinical Studies

April 24, 2024 —Hello Heart, a digital leader in preventive heart health, today announced results from its latest study ...

Home April 24, 2024
Home
News | Cardiovascular Clinical Studies

April 22, 2024 — Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, welcomes the ...

Home April 22, 2024
Home
News | Cardiovascular Clinical Studies

April 16, 2024 — CVRx, Inc., a commercial-stage medical device company, announced today the availability of additional ...

Home April 16, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — Transcatheter aortic valve replacement (TAVR) was found to bring no increased risks and was associated ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — People with a buildup of fatty atherosclerotic plaque in the heart’s arteries considered at risk of ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Patients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment ...

Home April 09, 2024
Home
Subscribe Now